Press release
Diabetic Neuropathy Market Size USD 6,298.1 MN By 2031 Key Pharma Players Investing | Japan Updates - 2025
Diabetic Neuropathy Market
Latest Japan News on Diabetic Neuropathy (2025)
In April 2025, a Japan-based pharmaceutical company, Ono Pharmaceutical, announced a Phase 2 clinical trial for a novel drug targeting painful diabetic peripheral neuropathy (DPN). The trial is focused on evaluating the safety and efficacy of a selective sodium channel blocker, showing promise in reducing nerve pain without central nervous system side effects.
Unlock exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://datamintelligence.com/download-sample/diabetic-neuropathy-market?kb
Diabetic Neuropathy Market Overview
Diabetic neuropathy refers to nerve damage caused by diabetes, often leading to pain, numbness, and weakness, primarily in the legs and feet. The market includes diagnostics, treatment options like pain relief medications, and ongoing R&D to manage or prevent nerve complications in diabetic patients.
Research Methodology:
The global Diabetic Neuropathy Market research report is based on a combination of primary and secondary data sources. The study carefully analyzes various factors influencing the industry, including government regulations, market dynamics, competitive landscape, historical trends, current conditions, and technological progress. It also evaluates future developments, related industry trends, market volatility, growth prospects, potential obstacles, and emerging challenges.
Segment Covered in the Diabetic Neuropathy Market:
By Type: Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy.
By Drug Class: Anti-Depressant, Anti-Convulsant, Opioids, NSAIDs, Others.
By Distribution Channel: Hospitals and Clinics Pharmacy, Retail Pharmacy and Stores, Online Pharmacy.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/diabetic-neuropathy-market?kb
List of the Key Players in the Diabetic Neuropathy Market:
Depomed pharma, Eli Lilly, Daiichi Sankyo, Teva Pharmaceutical Industries Ltd., Xenoport, Grünenthal, Johnson and Johnson, Pfizer, GlaxoSmithKline and Boehringer Ingelheim among others.
Industry Development:
In March 2022, Daiichi Sankyo Company Limited, a prominent global healthcare innovator, received regulatory approval in Japan to broaden the indications for its Tarlige Tablets (mirogabalin besilate). Initially approved for treating peripheral neuropathic pain, the new approval extends its use to cover a wider range of neuropathic pain conditions-enabling more patients to benefit from this effective analgesic therapy.
In July 2022, Teva Pharmaceutical Industries Ltd. and NeuroFront Therapeutics (Hong Kong) Limited announced a strategic collaboration through an exclusive licensing and commercialization agreement. This partnership aims to advance the development of NRD.E1, a novel non-opioid investigational drug originally developed by Novaremed. NRD.E1 is being explored as a treatment for diabetic neuropathic pain and other neuropathic pain disorders, representing a major step toward offering safer, non-opioid alternatives for chronic pain management.
Regional Analysis for Diabetic Neuropathy Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
The Report Includes:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.
People Also Ask:
➠ What are the global sales, production, consumption, imports, and exports in the Diabetic Neuropathy market?
➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?
➠ What key opportunities and challenges do vendors face in the Diabetic Neuropathy industry?
➠ Which product types, applications, or end-users are driving market growth, and what is their market share?
➠ What are the major growth drivers and restraints of the Diabetic Neuropathy market?
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Neuropathy Market Size USD 6,298.1 MN By 2031 Key Pharma Players Investing | Japan Updates - 2025 here
News-ID: 4073040 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
United States Natural Caffeine Market: Supply Chain & Coffee Price Volatility | …
Market Size and Forecast:
Global Natural Caffeine Market reached US$ 3.4 billion in 2023 and is expected to reach US$ 5.27 billion by 2031, growing with a CAGR of 5.6% during the forecast period 2024-2031.
The Natural Caffeine Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and…
United States Sustainable Pharmaceutical Packaging Market: 12.7% CAGR to US$ 316 …
Market Size and Forecast:
Sustainable Pharmaceutical Packaging Market size reached US$ 91.94 Billion in 2024 and is expected to reach US$ 316.05 Billion by 2033, growing at a CAGR of 12.7% during the forecast period 2025-2033, according to DataM Intelligence report.
The Global Sustainable Pharmaceutical Packaging Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM…
United States Ultra High Performance Concrete (UHPC) Market 2025 | Infrastructur …
DataM Intelligence has published a new research report on "Ultra High Performance Concrete Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Pre-packaged UHPC is priced at over…
United States Automotive Artificial Intelligence (AI) Industry Sector Growth to …
DataM Intelligence has published a new research report on "Automotive Artificial Intelligence Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This…
More Releases for Neuropathy
Neuropathy Care Centers Launches National Push to Rethink Peripheral Neuropathy …
A healthcare organization builds out a collaborative model aimed at earlier intervention and improved patient understanding
WHEATON, IL - July 14, 2025 - Neuropathy Care Centers, a Wheaton-based healthcare organization, today announced the expansion of its national initiative to improve how Peripheral Neuropathy is identified and managed across the U.S. The organization is developing a growing network of providers focused on early detection and conservative, nerve-focused care, an effort intended to…
Chemotherapy Induced Peripheral Neuropathy Market Trends and Insights, Toward Sa …
Overview of the Market
Chemotherapy Induced Peripheral Neuropathy (CIPN) is one of the most common and debilitating side effects of cancer treatment, affecting a significant portion of chemotherapy patients. CIPN occurs when chemotherapy drugs cause damage to the peripheral nerves, leading to symptoms such as numbness, tingling, burning sensations, and pain, primarily in the hands and feet. With the growing global prevalence of cancer, the incidence of CIPN is also rising,…
Prominent Diabetic Peripheral Neuropathy Market Trend for 2025: Advancements In …
What industry-specific factors are fueling the growth of the diabetic peripheral neuropathy market?
The increase in obesity-related health issues is expected to drive the growth of the diabetic peripheral neuropathy (DPN) market. Obesity, characterized by excessive body fat accumulation, significantly increases the risk of chronic diseases, including type 2 diabetes. This, in turn, heightens the occurrence of diabetic peripheral neuropathy, a complication where high blood sugar levels cause nerve damage. The…
Major Market Shift in Peripheral Neuropathy Industry: Technological Advancements …
What Is the Forecasted Market Size and Growth Rate for the Peripheral Neuropathy Market?
The size of the peripheral neuropathy market has seen a rapid expansion in recent years, set to increase from $4.09 billion in 2024 to $4.62 billion in 2025, representing a compound annual growth rate (CAGR) of 13.2%. This growth during the historical period is due to a variety of factors including the rising prevalence of chronic illnesses…
Multifocal Motor Neuropathy Market - Progress in nerve restoration: Driving adva …
Newark, New Castle, USA: The "Multifocal Motor Neuropathy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Multifocal Motor Neuropathy Market: https://www.growthplusreports.com/report/multifocal-motor-neuropathy-market/8810
This latest report researches the industry structure,…
Optic Neuropathy Management Market Rising cases of optic neuropathy and advancem …
Global Optic Neuropathy Management Market Overview:
The Optic Neuropathy Management market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Optic Neuropathy Management market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth…
